Ground Swell Capital’s Co-Diagnostics CODX Stock Holding History

Ground Swell Capital’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-384	Closed	-$3.96K	–	105
2025 Q3	$3.96K	Buy	+384	New	+$3.57K	0.01%	128

Other funds holding CODX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAG

Private Advisory Group Redmond, Washington $1.85B AUM 50.66% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ground Swell Capital's CODX Position: Q4 2025 in Review

Ground Swell Capital sold out of Co-Diagnostics (CODX) in Q4 2025, closing a stake of 384 shares — an estimated $3.96K sold.

Ground Swell Capital first reported a position in CODX in Q3 2025 and held it in 1 quarter. The position peaked at $3.96K in Q3 2025. 30 funds tracked by Wall St. Rank hold CODX as of Q4 2025.

Ground Swell Capital reported no remaining Co-Diagnostics position as of Q4 2025 after selling out during the quarter.
Ground Swell Capital sold 384 Co-Diagnostics shares in Q4 2025, an estimated $3.96K.
Ground Swell Capital first reported a position in Co-Diagnostics in Q3 2025 and held it in 1 quarter.
Ground Swell Capital's Co-Diagnostics position peaked at $3.96K in Q3 2025.
30 funds tracked by Wall St. Rank held Co-Diagnostics as of Q4 2025.

Based on Ground Swell Capital's 13F filing for Q4 2025, filed 4 Feb 2026.